Get this goingall that will really get this going is a merger/distribution deal with a Major Pharma, or a fda approval/HC something of sorts.their integration into the US market strongly shows their interest in getting product distribution going on a large scale,having this stock been listed on NASDAQ you would have seen pumps up to double what we have seen but probably dumps back to .05 as well.Im a beliver this company will eventually get some deals with large Pharmas for worldwide distribution with overseas fda approvals.2 year price target 7-10 dollars. but alot of ups and downs along the way.